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Summary Two hundred and thirteen lung tumours of primary site and 42 metastases were hetero-
transplanted into nude mice with an overall success rate of 44%. There were differences in success between
the histological types. Squamous cell and adenocarcinoma had the highest success rate (51% and 43%,
respectively) whereas large cell and small cell carcinoma had a lower success rate (38% for both). The average
volume doubling times in the first passage in nude mice ranged from 8.2 in large cell carcinomas to 18.9 days
in adenocarcinomas. In subsequent passages an increase in growth rate was found, the overall average
doubling time falling from 14.5 days in the first passage to 7.1 days in the second passage. In a study with
171 non-small cell lung carcinomas (NSCLC), the growth data in nude mice were correlated with the clinical
data of the corresponding patients. A relationship between the growth parameters in nude mice and prognosis
of patients could not be found.
During the past 3 years we have transplanted in the
course of cooperative clinical studies 255 human
lung tumours into nude mice. In this report we
describe the incidence and rate of growth of these
tumours in the nude mouse, as primary transplants
and passaged tumours, and further we examined
whether the growth characteristics of these tumours
might be of clinical prognostic value. Comparison
of a part of the presented data with other
measurements and the clinical course will be
published elsewhere.
Materials and methods
Nude mice
Athymic nude NMRI-mice (own breeding or
Zentralinstitut fur Versuchstierzucht, Hannover),
female, 6-9 weeks old, were kept under
standardized conventional conditions (Makrolon
cages, 270C room temperature, 50% relative
humidity, autoclaved bedding) in a separated room
especially controlled against infections. An
autoclaved special diet (altromin 1410, Altromin
Spezialfutterwerke, D-4937 Lage) and acidified
water (pH 2-3) were given ad libitum.
Patients and tumours
Two hundred and fifty five histologically verified
lung tumours and their lymph node metastases
from 213 patients were xenografted into nude mice.
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The tumour material was obtained by surgical
removal from patients of the Rohrbach Hospital,
Heidelberg.
The histological examination of the tumours was
performed by two pathologists. The morphological
classification of the bronchial carcinomas was based
on the WHO study (1981). For the comparison of
the growth data in nude mice with clinical data,
171 patients with non-small cell lung carcinomas,
whose tumours were heterotransplanted between
August 1980 and October 1982, were included in
the study.
Of these 171 patients, 131 (i.e. 77%) only had
surgical removal of the tumour; 40 patients were
additionally given chemotherapy or radiation. The
survival times were determined from the day of
operation. The clinical data were stored by the
central data processing system of the German
Cancer Research Center (IBM 3032, TSS operation
system). The method for the analysis is the
statistical failure time model with censored data by
Kaplan-Meier. For the comparison of the survivor
functions from different populations rank test
based on exponential respectively Wilcoxon scores
are used.
Method of tumour implantation
The tumour specimens used for transplantation
were removed under aseptic conditions. In the
laboratory, the specimens were finely minced with
scissors and suspended in Hanks salt solution.
Enough medium was added to reach a
tissue:medium ratio of 1:3 by volume. Three
hundred microlitres of each suspension (> 107
cells/mouse) were injected s.c. into the flanks of 3
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animals each with a 1.4 mm trochar needle. Human
tumours growing in nude mice were serially
transplanted from mouse to mouse by s.c. injection
of minced tumour tissue after the tumours had
reached a size of_ 100 mm2 (two diameters).
Tumour take
Tumour take was assumed when within 3 months
the presence of growing nodules was noted and
confirmed histologically.
Determination of tumour size and doubling time
The tumour nodules were measured twice a week
with a slide caliper (two diameters) for 3 months or
until the time of further transplantation. In animals
the tumour doubling time was determined by the
method of Collins et al. (1956). The mean diameter
for each tumour was plotted on a semilogarithmic
paper to establish the time required for the tumour
to double its volume. Doubling time was used to
measure growth rate.
The index of tumour growth in the patient was
determined as a ratio between size of the tumour
and the duration of symptoms (size/duration) in
each individual patient. This represented a measure
of the rapidity of tumour enlargement. High index
indicated fast growth and low index corresponded
to slow growth.
FCM-analysis
Tumours were dispersed into single-cell suspensions
and fixed in methanol. Preparation and cell cycle
analysis were performed as previously described
(Sonka et al., 1983), using a flow cytofluorometer
(ICP 22, Phywe).
Results
Success rate of tumour takes
Two hundred and fifty five lung tumours from 213
patients were xenografted into nude mice. The
success rate for each histological category is shown
in Table I. Also included in this report are take rate
of lung tumours as already described (Mattern et
al., 1981). The overall success rate for tumours of
primary site was 45%. It was found that all four
main histopathological types of bronchial
carcinoma could be grown as xenografts. Squamous
cell carcinomas and adenocarcinomas gave a higher
take rate (51% and 43%) than large cell or small
cell carcinomas (38% for both).
It was more difficult to establish cell lines from
adenocarcinomas than from other histological
types. In primary transplants the percentage of
takes was higher for tumours ofprimary sites (45%)
then for metastases (36%) or recurrences (40%)
(Table II), however, these differences were not
statistically significant.
Table I Success rate of bronchial carcinomas of primary site in nude mice
with reference to histological type.
No. oftumours No. oftumours
Histology tested growing (%) No. oflines (%)
Squamous 104 53 (51) 39 (38)
Adeno 56 24 (43) 8 (14)
Large cell 29 11 (38) 8 (27)
Small cell 16 6 (38) 3 (19)
Miscellaneous 8 2 1
Total 213 96 (45) 59 (28)
Table II Success rate of bronchial carcinomas in nude mice with reference to
site of tumour.
No. oftumours No. oftumours
Tumour tested growing (%) No. oflines (%)
Primary 203 92 (45) 56 (28)
Metastases 42 15 (36) 11 (26)
Recurrences 10 4 (40) 3 (30)
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Growth rates
A summary of growth rate data is given in Table
III. The measurements were usually made on
tumours in the size range of 8-12mm diameter.
Not all cases as shown in Table II reached a stage in
which this determination of growth rate could be
made. It can be seen that in the first passage the
volume doubling time range from 8.2 days in large
cell carcinomas to 18.9 days in adenocarcinomas
(the latter having a broad range). In the subsequent
Table III Volume doubling times (in days)
of bronchial carcinomas growing as xeno-
grafts in the first passage in nude mice.
Histology n mean median range
Squamous 40 16.6 14.6 3.5-61
Adeno 11 18.9 13 6.6-40.4
Large cell 8 8.2 8.1 3.6-16.3
Small cell 3 11.1 11.4 3-19
passages an increase in growth rate was found in
nearly all tumours, the overall average doubling
time falling from 14.7 days in the first passage to
7.1 days in the second passage and remaining stable
around 5 to 6 days up to the 8th passage.
Comparison ofgrowth characteristics ofxenograft
with clinical course ofpatient
In order to examine whether growth characteristics
of untreated tumours in nude mice might be of
clinical significance, we compared the growth data
of the xenografts with the clinical data of the
corresponding patients. This study included 171
patients with non-small cell lung carcinomas.
In Table IV take rates, establishment of lines and
doubling times of tumours in the first passage in
nude mice are shown in relation to clinical data. It
can be demonstrated that there is no significant
difference in takes and doubling times between the
various clinical factors. However, there exists a
Table IV Correlation of growth parameters in nude mice with clinical data
Growth in Ith passage Td in Ith passage Establishment oftumour lines
No. growingl Days No. oflines!
No. attempted (%) P-valuea Total No. (median) No. attempted (%) P-value
Histology
squamous 46/93 49 40 15 35/93 38
adeno 21/49 43 n.s. 11 13 7/49 14 P=0.01b
large-cell 11/29 38 8 8 8/29 27
T
1 4/8 50 2 20 2/8 25
2 19/46 41 n.s. 15 10 12/46 26 n.s.
3 54/115 47 42 13 36/115 31
N
0 27/74 50 28 15 22/74 30
1 40/94 42 n.s. 31 11 28/94 30 n.s.
Age
20-49 10/24 42 30 12 7/24 29
50-59 35/78 45 n.s. 23/78 29 n.s.
60-69 23/49 47 14/49 28
70-99 10/19 53 29 15 6/19 31
Ploidy
diploid 7/24 29 n.s. 5 17 3/24 12 P=0.04
aneuploid 57/115 50 42 11 39/115 34
SG2M
<22% 18/50 36 n.s. 12 13 9/50 18 P=0.04
>22% 24/47 51 16 13 17/47 36
Tumour volume
<70cm3 (median) 38/79 48 n.s. 28 16 20/79 25 n.s.
> 70cm3 34/79 43 28 9 27/79 34
Size of tumour/
duration of symptoms
<9.55 (median) 29/65 45 n.s. 22 15 19/65 29 n.s.
>9.55 36/78 46 28 9 25/78 32
ado =0.05
badeno versus squamous: P=0.004198 J. MATTERN et al.
significant relationship between establishment of
tumour lines and histology, ploidy and proliferative
pool (S+G2+M)-
In order to study whether take rate,
establishment of lines or the growth rate in the first
passage in nude mice is of prognostic significance,
we divided the NSCL-carcinomas into groups
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depending on whether they have shown growth or
not, established a line or not or doubling times
were shorter or longer than 13 days. These groups
were correlated with the survival time of the
corresponding patients (Figure 1). We did not find
a relationship between the growth parameters in
nude mice and prognosis ofpatients.
b
1 UU-
80-
,60- 2-
0 c,,6
"> 40-
20 -
0
Time after operation (weeks)
I N+
I' nogrowth
growth ~'.
total/adea
growth: 32/27
no P = 0.0781 growth: 50/34
. . . .....I........... ..
25 50 75 100 125
Time after operation (weeks)
150
N-
-z---, tumorline
no tumorlinel
total/dead
line : 19/ 8 P 0.6
no line: 51/26
... ...
I~ ., . 0..
. . . . . .
25 50 75 100 125 150
Time after operation (weeks)
total/dead
20- Td > 13 : 14/8
-Td = <13: 10/ 3 P=0.45
,|xW
0 25 50 75 10 125 150
Time after operation (weeks)
0
_,
d
100-- N
80- "f,
60 ' >gtumorline
0 totumorline
40
20 - total/dead -------
line 23/19
no line 59/42 P0.12
0 25 50 75 100 125 150
Time after operation (weeks)
f
100 -
'+ ~~~N+
80-
0I0
o,60 Td>13 C 13
40- LTd=<13
en L~~~--------------1
20- total/dead--- Td > 13 :11/10
Td= < 13: 13/11 P= 0.51 o- ....-,.... ............
0 25 50 75 100 125 150
Time after operation (weeks)
Figure 1 Survival time of patients with non-small cell lung cancer subdivided according to a, b: growth or
not in nude mice; c,d: establishment of lines or not in nude mice; e, f: tumor doubling time shorter or larger
than 13 days in nude mice. The corresponding P-values are indicated in the figure.
N-: patients with negative lymph nodes
N+: patients with positive lymph nodes.
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Discussion
Human solid tumours have now been
heterotransplanted to the nude mouse (Fogh et al.,
1980; Rofstad et al., 1982) or immune-deprived
animals (Houghton & Taylor, 1978; Steel et al.,
1983) in many laboratories. Our overall success rate
of 44% with lung tumours agrees well with the
experience of other workers (Sharkey et al., 1978;
Shorthouse et al., 1980). There were, however,
differences in success between the histological types
of heterotransplanted tumours. Shorthouse et al.
(1980) have reported highest take rates for large cell
and adenocarcinomas, whereas our success rate was
highest with squamous cell carcinomas, however,
the differences between the histological types are
not significant. Gazdar et al. (1981). reported
successful heterotransplantation in 13/29 (45%)
small cell carcinomas; our success rate was in the
same range (6/16; 38%). In contrast to the
previously described studies are the results reported
by Schuchhardt et al. (1983). They observed an
overall success rate of 76% with human lung
carcinomas. These differences may be due partly to
the definition "tumour take". It should be noted
that in our studies and also in reports of other
workers, a successful take was defined as
progressive growth of a tumour; histological
evidence of "viability" in a static nodule was not
counted as a take. However, it is clear that several
factors can affect success or failure of tumours to
grow; for instance, size of inoculum, technique and
location of implantation.
Fogh et al. (1980) demonstrated that metastases
will grow more readily than will tumours of
primary sites. This cannot be confirmed with our
tumour material. Takes were higher for tumours of
primary site (45%) than for lymph node metastases
(36%) or recurrent tumours (40%).
The majority of lung carcinoma xenografts
studied in the present work showed volume
doubling times between 10 and 20 days (Table III).
Similar volume doubling times have been reported
by other workers in nude mice (Rofstad et al.,
1982) and in immune-deprived mice (Steel et al.,
1983). These volume doubling times are
considerably shorter than those measured in man.
Lung carcinomas have been found to have a wide
range of growth rates with an average of -90 days
(Straus et al., 1983). Whatever the reasons may be
for the short volume doubling times of the
xenografts (e.g. reduced cell loss, difference in
tumour volume, etc.), the rank within the different
histological types remains the same (Straus et al.,
1983; Table III). Large cell carcinoma which has
been reported to grow faster than epidermoid or
adenocarcinomas is also the tumour type which has
the shortest doubling times in xenografted tumours
in the first passage.
If tumours growing in the first passage in nude
mice are successively transplanted, a further
acceleration occurs between the first and second
passages. In our study the overall average doubling
time fell from 14.7 days to 7.1 days and remained
fairly stable in the succeeding passages. This growth
acceleration during the first few transplant
generation has also been observed by other workers
(Shimosato et al., 1976; Steel et al., 1983). There
appeared to be adaptation to growth of tumours in
nude mice with succeeding passages.
There is evidence that growth of human tumours
in nude mice and establishment of tumour lines is
related to prognosis (Neely et al., 1983). Our results
with xenografted non-small cell lung carcinomas
and the comparison with clinical data indicate that
success in establishing growth is not dependent on
histology, tumour size, lymph node involvement
nor age of the patients. Only aneuploid tumours, as
shown by flow cytometry, have a better success rate
than diploid tumours. However, the difference is
not significant. On the other hand, there exists a
significant relationship between establishment of
lines and histology, ploidy and proliferative pool.
In order to study the prognostic value of these
growth parameters in nude mice, we divided
patients into two groups depending on whether
their tumours showed growth or not and correlated
the two groups with the clinical data of the corres-
ponding patients. There was a trend in survival
between the two groups suggesting that tumours
successfully grown in nude mice were more likely to
behave aggressively in the patient; however, the
difference was not significant.
In summary, the results show that despite certain
significant data on growth of xenografts in nude
mice, this model is of no prognostic value.
We thank M. Vogt-Schaden for operating the flow
cytometry, P. Drings, H. Liillig, H. Toomes and I. Vogt-
Moykopf for providing the tumour material, and K.
Kayser and D. Komitowski for histological examination.200 J. MATTERN et al.
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